Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Nandakumar Natarajan"'
Autor:
Tharmarajan Ramprasath, Nandakumar Natarajan, Jacob Gopas, Ramasamy Subbiah, Peramaiyan Rajendran, Sakthivel Vaiyapuri
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/ec0d64c4bb654abdaece13f7d9ef827d
Autor:
Anxi Hu, Abdullah A. Alarfaj, Abdurahman Hajinur Hirad, Vishnu Priya Veeraraghavan, Krishna Mohan Surapaneni, Samer Hasan Hussein-Al-Ali, Nandakumar Natarajan, Poorni Kaliyappan Elayappan
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 6, Pp 103844- (2022)
Background: Esophageal cancer is a sixth most cause of cancer-associated mortalities worldwide with increased global prevalence in each year. It has a poor prognosis with 5-year survival rate are less than 10%. Objective: The present study was focuse
Externí odkaz:
https://doaj.org/article/09180314e0174fec8b20b2a2448bbecf
Autor:
Ramsi Vakayil, Srinivasan Ramasamy, Tahani Awad Alahmadi, Hesham S. Almoallim, Nandakumar Natarajan, Maghimaa Mathanmohun
Publikováno v:
Applied Nanoscience. 12:2873-2887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::439ea538e0c31df06ea68ddfe7e0d0c9
https://doi.org/10.1007/s13204-022-02573-9
https://doi.org/10.1007/s13204-022-02573-9
Autor:
Qian Zhang, Kavitha kandasamy, Nouf M. Alyami, Hanadi M. Alyami, Nandakumar Natarajan, Poorni Kaliyappan Elayappan
Publikováno v:
Applied Biochemistry and Biotechnology. 194:5945-5962
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1a4f2a38bd2ef8c6b961e5f22cd0de
https://doi.org/10.1007/s12010-022-04045-w
https://doi.org/10.1007/s12010-022-04045-w
Autor:
Cheng Li, Saleh H. Salmen, Tahani Awad Alahmadi, Vishnu Priya Veeraraghavan, Krishna Mohan Surapaneni, Nandakumar Natarajan, Senthilkumar Subramanian
Publikováno v:
Saudi Journal of Biological Sciences. 29:3354-3365
Nano-based drug delivery systems have shown several advantages in cancer treatment like specific targeting of cancer cells, good pharmacokinetics, and lesser adverse effects. Liver cancer is a fifth most common cancer and third leading cause of cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87878ff7db9c9331f0e5fb399e99e55
https://doi.org/10.1016/j.sjbs.2022.02.012
https://doi.org/10.1016/j.sjbs.2022.02.012
Autor:
Xiaoqian Zhao, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Nandakumar Natarajan, Muthusamy Raman
Background Colon cancer is the most prevalent cancer and causes the highest cancer-associated mortality in both men and women globally. It has a high incidence and fatality rate, which places a significant burden on the healthcare system. Objective T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26dbd0a1123f0e0dfa9526b7e94783db
https://doi.org/10.21203/rs.3.rs-2430794/v1
https://doi.org/10.21203/rs.3.rs-2430794/v1
Autor:
Rajendran, Peramaiyan, Rengarajan, Thamaraiselvan, Nandakumar, Natarajan, Palaniswami, Rajendran, Nishigaki, Yutaka, Nishigaki, Ikuo
Publikováno v:
In European Journal of Medicinal Chemistry 30 October 2014 86:103-112
Autor:
Rengarajan, Thamaraiselvan, Rajendran, Peramaiyan, Nandakumar, Natarajan, Balasubramanian, Maruthaiveeran Periyasamy, Nishigaki, Ikuo
Publikováno v:
In Asian Pacific Journal of Tropical Disease October 2014 4(5):384-390
Autor:
Rengarajan, Thamaraiselvan, Nandakumar, Natarajan, Balasubramanian, Maruthaiveeran Periyasamy
Publikováno v:
In Biomedicine & Preventive Nutrition January-March 2013 3(1):31-41
Autor:
Rengarajan, Thamaraiselvan, Nandakumar, Natarajan, Balasubramanian, Maruthaiveeran Periyasamy
Publikováno v:
In Biomedicine & Aging Pathology July-September 2012 2(3):85-93